Lonotropic Glutamate Receptor Antagonist - Global and China Top Players Market Share and Ranking 2024
Ionic glutamate receptor antagonists, including: the N-methyl-D-aspartate receptor, the maricin receptor, and the alpha-amino-3-hydroxy-5 methyl-4 isoxazole receptor, which are coupled to ion channels to form receptor channel complexes that mediate fast signalling.
This report studies and analyses global Lonotropic Glutamate Receptor Antagonist status and future trends, helps the client to determine the Lonotropic Glutamate Receptor Antagonist market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Lonotropic Glutamate Receptor Antagonist, and provides market size (in Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Lonotropic Glutamate Receptor Antagonist market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Units)
(2) Global Lonotropic Glutamate Receptor Antagonist sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Units)
(3) China Lonotropic Glutamate Receptor Antagonist sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Units)
(4) Global Lonotropic Glutamate Receptor Antagonist key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Lonotropic Glutamate Receptor Antagonist key producing regions, capacity, production, and year over year growth
(6) Lonotropic Glutamate Receptor Antagonist industry chains, upstream, midstream and downstream
According to latest study, the global market for Lonotropic Glutamate Receptor Antagonist should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Lonotropic Glutamate Receptor Antagonist market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Lonotropic Glutamate Receptor Antagonist market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospitals grew percent to account for percent of the total market sales, and Clinics grew percent.
Market segment by players, this report covers
Artemis Neuroscience
VistaGen Therapeutics
Rottapharm Madaus
Amorsa Therapeutics
Newron Pharmaceuticals
Purdue Biopharma
Relmada Therapeutics
BioCrea GmbH
Cerecor Inc.
NeurOp Inc.
UCB SA
Novartis AG
Luc Therapeutics Inc.
Evotec AG
Market segment by Type, covers
N-Methyl-D-Aspartate Receptors
Marine Human Alginate Receptors
α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors
Market segment by Application, can be divided into
Hospitals
Clinics
Research Institutes
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Lonotropic Glutamate Receptor Antagonist product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Lonotropic Glutamate Receptor Antagonist market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Lonotropic Glutamate Receptor Antagonist market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Lonotropic Glutamate Receptor Antagonist, percent & CAGR, 2018-2029
Chapter 5: Lonotropic Glutamate Receptor Antagonist industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Lonotropic Glutamate Receptor Antagonist Definition
1.2 Global Lonotropic Glutamate Receptor Antagonist Market Size and Forecast
1.2.1 By Consumption Value, Global Lonotropic Glutamate Receptor Antagonist Market Size，2018-2029
1.2.2 By Sales Quantity, Global Lonotropic Glutamate Receptor Antagonist Market Size，2018-2029
1.2.3 Global Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP)，2018-2029
1.3 China Lonotropic Glutamate Receptor Antagonist Market Size and Forecast
1.3.1 By Consumption Value, China Lonotropic Glutamate Receptor Antagonist Market Size，2018-2029
1.3.2 By Sales Quantity, China Lonotropic Glutamate Receptor Antagonist Market Size，2018-2029
1.3.3 China Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP)， 2018-2029
1.4 Share of China Lonotropic Glutamate Receptor Antagonist Market with Respect to the Global Market
1.4.1 By Consumption Value, China Lonotropic Glutamate Receptor Antagonist Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Lonotropic Glutamate Receptor Antagonist Market Share in Global, 2018-2029
1.4.3 Lonotropic Glutamate Receptor Antagonist Market Size: China VS Global, 2018-2029
1.5 Lonotropic Glutamate Receptor Antagonist Market Dynamics
1.5.1 Lonotropic Glutamate Receptor Antagonist Market Drivers
1.5.2 Lonotropic Glutamate Receptor Antagonist Market Restraints
1.5.3 Lonotropic Glutamate Receptor Antagonist Industry Trends
1.5.4 Lonotropic Glutamate Receptor Antagonist Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Lonotropic Glutamate Receptor Antagonist, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Lonotropic Glutamate Receptor Antagonist, Global Market Share by Company, 2018-2023
2.3 Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Lonotropic Glutamate Receptor Antagonist Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Lonotropic Glutamate Receptor Antagonist Concentration Ratio
2.6 Global Lonotropic Glutamate Receptor Antagonist Mergers & Acquisitions, Expansion Plans
2.7 Global Lonotropic Glutamate Receptor Antagonist Manufacturers Product Type
2.8 Head Office and Lonotropic Glutamate Receptor Antagonist Production Site of Key Manufacturer
2.9 Lonotropic Glutamate Receptor Antagonist Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Lonotropic Glutamate Receptor Antagonist, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Lonotropic Glutamate Receptor Antagonist, China Market Share by Company, 2018-2023
3.3 China Lonotropic Glutamate Receptor Antagonist Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Lonotropic Glutamate Receptor Antagonist Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Lonotropic Glutamate Receptor Antagonist Capacity by Region
4.3 Global Lonotropic Glutamate Receptor Antagonist Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Lonotropic Glutamate Receptor Antagonist Production by Region, 2018-2029
4.5 Global Lonotropic Glutamate Receptor Antagonist Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Lonotropic Glutamate Receptor Antagonist Industry Chain
5.2 Lonotropic Glutamate Receptor Antagonist Upstream Analysis
5.2.1 Lonotropic Glutamate Receptor Antagonist Core Raw Materials
5.2.2 Main Manufacturers of Lonotropic Glutamate Receptor Antagonist Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Lonotropic Glutamate Receptor Antagonist Production Mode
5.6 Lonotropic Glutamate Receptor Antagonist Procurement Model
5.7 Lonotropic Glutamate Receptor Antagonist Industry Sales Model and Sales Channels
5.7.1 Lonotropic Glutamate Receptor Antagonist Sales Model
5.7.2 Lonotropic Glutamate Receptor Antagonist Typical Distributors
6 Sights by Type
6.1 Lonotropic Glutamate Receptor Antagonist Classification
6.1.1 N-Methyl-D-Aspartate Receptors
6.1.2 Marine Human Alginate Receptors
6.1.3 α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors
6.2 By Type, Global Lonotropic Glutamate Receptor Antagonist Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029
6.4 By Type, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029
6.5 By Type, Global Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Lonotropic Glutamate Receptor Antagonist Segment by Application
7.1.1 Hospitals
7.1.2 Clinics
7.1.3 Research Institutes
7.1.4 Others
7.2 By Application, Global Lonotropic Glutamate Receptor Antagonist Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029
7.4 By Application, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029
7.5 By Application, Global Lonotropic Glutamate Receptor Antagonist Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029
8.3 By Region, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Lonotropic Glutamate Receptor Antagonist & Forecasts, 2018-2029
8.4.2 By Country, North America Lonotropic Glutamate Receptor Antagonist Market Size Market Share
8.5 Europe
8.5.1 Europe Lonotropic Glutamate Receptor Antagonist Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Lonotropic Glutamate Receptor Antagonist Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Lonotropic Glutamate Receptor Antagonist Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Lonotropic Glutamate Receptor Antagonist Market Size Market Share
8.7 South America
8.7.1 South America Lonotropic Glutamate Receptor Antagonist Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Lonotropic Glutamate Receptor Antagonist Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Lonotropic Glutamate Receptor Antagonist Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029
9.3 By Country, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029
9.4.2 By Type, U.S. Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029
9.5.2 By Type, Europe Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029
9.6.2 By Type, China Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029
9.7.2 By Type, Japan Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029
9.8.2 By Type, South Korea Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029
9.10.2 By Type, India Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Artemis Neuroscience
10.1.1 Artemis Neuroscience Company Information, Head Office, Market Area, and Industry Position
10.1.2 Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.1.3 Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Artemis Neuroscience Company Profile and Main Business
10.1.5 Artemis Neuroscience Recent Developments
10.2 VistaGen Therapeutics
10.2.1 VistaGen Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.2.2 VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.2.3 VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 VistaGen Therapeutics Company Profile and Main Business
10.2.5 VistaGen Therapeutics Recent Developments
10.3 Rottapharm Madaus
10.3.1 Rottapharm Madaus Company Information, Head Office, Market Area, and Industry Position
10.3.2 Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.3.3 Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Rottapharm Madaus Company Profile and Main Business
10.3.5 Rottapharm Madaus Recent Developments
10.4 Amorsa Therapeutics
10.4.1 Amorsa Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.4.2 Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.4.3 Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Amorsa Therapeutics Company Profile and Main Business
10.4.5 Amorsa Therapeutics Recent Developments
10.5 Newron Pharmaceuticals
10.5.1 Newron Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.5.2 Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.5.3 Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Newron Pharmaceuticals Company Profile and Main Business
10.5.5 Newron Pharmaceuticals Recent Developments
10.6 Purdue Biopharma
10.6.1 Purdue Biopharma Company Information, Head Office, Market Area, and Industry Position
10.6.2 Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.6.3 Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Purdue Biopharma Company Profile and Main Business
10.6.5 Purdue Biopharma Recent Developments
10.7 Relmada Therapeutics
10.7.1 Relmada Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.7.2 Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.7.3 Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Relmada Therapeutics Company Profile and Main Business
10.7.5 Relmada Therapeutics Recent Developments
10.8 BioCrea GmbH
10.8.1 BioCrea GmbH Company Information, Head Office, Market Area, and Industry Position
10.8.2 BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.8.3 BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 BioCrea GmbH Company Profile and Main Business
10.8.5 BioCrea GmbH Recent Developments
10.9 Cerecor Inc.
10.9.1 Cerecor Inc. Company Information, Head Office, Market Area, and Industry Position
10.9.2 Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.9.3 Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Cerecor Inc. Company Profile and Main Business
10.9.5 Cerecor Inc. Recent Developments
10.10 NeurOp Inc.
10.10.1 NeurOp Inc. Company Information, Head Office, Market Area, and Industry Position
10.10.2 NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.10.3 NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 NeurOp Inc. Company Profile and Main Business
10.10.5 NeurOp Inc. Recent Developments
10.11 UCB SA
10.11.1 UCB SA Company Information, Head Office, Market Area, and Industry Position
10.11.2 UCB SA Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.11.3 UCB SA Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 UCB SA Company Profile and Main Business
10.11.5 UCB SA Recent Developments
10.12 Novartis AG
10.12.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position
10.12.2 Novartis AG Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.12.3 Novartis AG Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Novartis AG Company Profile and Main Business
10.12.5 Novartis AG Recent Developments
10.13 Luc Therapeutics Inc.
10.13.1 Luc Therapeutics Inc. Company Information, Head Office, Market Area, and Industry Position
10.13.2 Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.13.3 Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Luc Therapeutics Inc. Company Profile and Main Business
10.13.5 Luc Therapeutics Inc. Recent Developments
10.14 Evotec AG
10.14.1 Evotec AG Company Information, Head Office, Market Area, and Industry Position
10.14.2 Evotec AG Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
10.14.3 Evotec AG Lonotropic Glutamate Receptor Antagonist Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Evotec AG Company Profile and Main Business
10.14.5 Evotec AG Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Lonotropic Glutamate Receptor Antagonist Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Lonotropic Glutamate Receptor Antagonist Market Restraints
Table 3. Lonotropic Glutamate Receptor Antagonist Market Trends
Table 4. Lonotropic Glutamate Receptor Antagonist Industry Policy
Table 5. Global Lonotropic Glutamate Receptor Antagonist Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Lonotropic Glutamate Receptor Antagonist Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Lonotropic Glutamate Receptor Antagonist Sales Quantity by Company, (2018-2023) & (Units), Ranked Based on Sales in 2022
Table 8. Global Lonotropic Glutamate Receptor Antagonist Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Lonotropic Glutamate Receptor Antagonist Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Lonotropic Glutamate Receptor Antagonist Mergers & Acquisitions, Expansion Plans
Table 12. Global Lonotropic Glutamate Receptor Antagonist Manufacturers Product Type
Table 13. Head Office and Lonotropic Glutamate Receptor Antagonist Production Site of Key Manufacturer
Table 14. Lonotropic Glutamate Receptor Antagonist Capacity of Major Manufacturers and Future Plan
Table 15. China Lonotropic Glutamate Receptor Antagonist Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Lonotropic Glutamate Receptor Antagonist Sales Quantity by Company, (2018-2023) & (Units), Ranked Based on Sales in 2022
Table 17. China Lonotropic Glutamate Receptor Antagonist Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Lonotropic Glutamate Receptor Antagonist Production & Forecast by Region, 2018 VS 2022 VS 2029, (Units)
Table 19. Global Lonotropic Glutamate Receptor Antagonist Production by Region, 2018-2023, (Units)
Table 20. Global Lonotropic Glutamate Receptor Antagonist Production Forecast by Region, 2024-2029, (Units)
Table 21. Global Key Players of Lonotropic Glutamate Receptor Antagonist Upstream (Raw Materials)
Table 22. Global Lonotropic Glutamate Receptor Antagonist Typical Customers
Table 23. Lonotropic Glutamate Receptor Antagonist Typical Distributors
Table 24. By Type, Global Lonotropic Glutamate Receptor Antagonist Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Lonotropic Glutamate Receptor Antagonist Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Table 29. By Country, Global Lonotropic Glutamate Receptor Antagonist Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Table 33. By Country, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2018-2029
Table 34. Artemis Neuroscience Company Information, Head Office, Market Area, and Industry Position
Table 35. Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 36. Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Artemis Neuroscience Company Profile and Main Business
Table 38. Artemis Neuroscience Recent Developments
Table 39. VistaGen Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 40. VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 41. VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. VistaGen Therapeutics Company Profile and Main Business
Table 43. VistaGen Therapeutics Recent Developments
Table 44. Rottapharm Madaus Company Information, Head Office, Market Area, and Industry Position
Table 45. Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 46. Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Rottapharm Madaus Company Profile and Main Business
Table 48. Rottapharm Madaus Recent Developments
Table 49. Amorsa Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 50. Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 51. Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Amorsa Therapeutics Company Profile and Main Business
Table 53. Amorsa Therapeutics Recent Developments
Table 54. Newron Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 55. Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 56. Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Newron Pharmaceuticals Company Profile and Main Business
Table 58. Newron Pharmaceuticals Recent Developments
Table 59. Purdue Biopharma Company Information, Head Office, Market Area, and Industry Position
Table 60. Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 61. Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Purdue Biopharma Company Profile and Main Business
Table 63. Purdue Biopharma Recent Developments
Table 64. Relmada Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 65. Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 66. Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Relmada Therapeutics Company Profile and Main Business
Table 68. Relmada Therapeutics Recent Developments
Table 69. BioCrea GmbH Company Information, Head Office, Market Area, and Industry Position
Table 70. BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 71. BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. BioCrea GmbH Company Profile and Main Business
Table 73. BioCrea GmbH Recent Developments
Table 74. Cerecor Inc. Company Information, Head Office, Market Area, and Industry Position
Table 75. Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 76. Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Cerecor Inc. Company Profile and Main Business
Table 78. Cerecor Inc. Recent Developments
Table 79. NeurOp Inc. Company Information, Head Office, Market Area, and Industry Position
Table 80. NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 81. NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. NeurOp Inc. Company Profile and Main Business
Table 83. NeurOp Inc. Recent Developments
Table 84. UCB SA Company Information, Head Office, Market Area, and Industry Position
Table 85. UCB SA Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 86. UCB SA Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. UCB SA Company Profile and Main Business
Table 88. UCB SA Recent Developments
Table 89. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 90. Novartis AG Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 91. Novartis AG Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Novartis AG Company Profile and Main Business
Table 93. Novartis AG Recent Developments
Table 94. Luc Therapeutics Inc. Company Information, Head Office, Market Area, and Industry Position
Table 95. Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 96. Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Luc Therapeutics Inc. Company Profile and Main Business
Table 98. Luc Therapeutics Inc. Recent Developments
Table 99. Evotec AG Company Information, Head Office, Market Area, and Industry Position
Table 100. Evotec AG Lonotropic Glutamate Receptor Antagonist Models, Specifications, and Application
Table 101. Evotec AG Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Evotec AG Company Profile and Main Business
Table 103. Evotec AG Recent Developments
List of Figures
Figure 1. Lonotropic Glutamate Receptor Antagonist Picture
Figure 2. Global Lonotropic Glutamate Receptor Antagonist Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, (Units) & (2018-2029)
Figure 4. Global Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Lonotropic Glutamate Receptor Antagonist Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Lonotropic Glutamate Receptor Antagonist Sales Quantity (Units) & (2018-2029)
Figure 7. China Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Lonotropic Glutamate Receptor Antagonist Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Lonotropic Glutamate Receptor Antagonist Market Share of Global, 2018-2029
Figure 10. Global Lonotropic Glutamate Receptor Antagonist Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Lonotropic Glutamate Receptor Antagonist Key Participants, Market Share, 2022
Figure 12. Global Lonotropic Glutamate Receptor Antagonist Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Lonotropic Glutamate Receptor Antagonist Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Lonotropic Glutamate Receptor Antagonist Production Market Share & Forecast by Region, 2018-2029
Figure 15. Lonotropic Glutamate Receptor Antagonist Industry Chain
Figure 16. Lonotropic Glutamate Receptor Antagonist Procurement Model
Figure 17. Lonotropic Glutamate Receptor Antagonist Sales Model
Figure 18. Lonotropic Glutamate Receptor Antagonist Sales Channels, Direct Sales, and Distribution
Figure 19. N-Methyl-D-Aspartate Receptors
Figure 20. Marine Human Alginate Receptors
Figure 21. α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors
Figure 22. By Type, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 25. By Type, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Hospitals
Figure 28. Clinics
Figure 29. Research Institutes
Figure 30. Others
Figure 31. By Application, Global Lonotropic Glutamate Receptor Antagonist Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 34. By Application, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Lonotropic Glutamate Receptor Antagonist Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2018-2029
Figure 38. North America Lonotropic Glutamate Receptor Antagonist Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2022
Figure 40. Europe Lonotropic Glutamate Receptor Antagonist Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2022
Figure 42. Asia Pacific Lonotropic Glutamate Receptor Antagonist Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2022
Figure 44. South America Lonotropic Glutamate Receptor Antagonist Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Lonotropic Glutamate Receptor Antagonist Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Lonotropic Glutamate Receptor Antagonist Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 48. By Type, U.S. Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 51. By Type, Europe Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 54. By Type, China Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 57. By Type, Japan Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 60. By Type, South Korea Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 63. By Type, Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 66. By Type, India Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Lonotropic Glutamate Receptor Antagonist Sales Quantity, 2018-2029, (Units)
Figure 69. By Type, Middle East & Africa Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Lonotropic Glutamate Receptor Antagonist Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|